Advocate
-
WORLD HEPATITIS SUMMIT: NO ELIMINATION WITHOUT DECRIMINALIZATION! 18 civil society organisations call world leaders to promote harm reduction and decriminalise drug use
São Paulo, Brazil – November 2nd 2017.
At the occasion of the World Hepatitis Summit, a large coalition of patients, clinicians, social workers, representatives of the drug using community, researchers, and public health experts express their whole-hearted support to the commitment of the World (...) More -
Equitable access to HCV drugs
Petition to stop Gilead’s anti-diversion program that violates physician and patient rights to protect its profit. More
-
Forging A Path to HCV Elimination: Simpler Tests and Affordable Generics Report of the World Community Advisory Board on HCV Generics and Diagnostics 18-20 July 2017, Bangkok, Thailand
In July 2017, 37 treatment activists from 17 countries—including 14 low- and middle-income countries (LMICs)—met with representatives from three generics and three diagnostics companies. This Hepatitis C World Community Advisory Board meeting was an opportunity for activists to present demands (...) More
-
Implementation handbook Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia
Georgia has a huge burden of hepatitis C, with a national prevalence rate of 7.1% for HCV antibodies. People who inject drugs (PWID) are particularly affected and hence form a vulnerable group. A study conducted by Médecins du Monde in 2012 found that 92% of the PWID in Tbilissi had HCV (...) More
-
Dying at these prices: Generic HCV cure denied mapCrowd report #2
To mark the significance of World Hepatitis Day, Médecins du Monde (MdM) and Treatment Action Group (TAG) have produced a new report Dying at these prices: Generic HCV cure denied, based on crowdsourced hepatitis C data from over 40 countries available at mapCrowd.org. More